In this context, a study appearing in Frontiers of Medicine explores the potential of dronedarone, an FDA-approved drug, in inhibiting ESCC proliferation through the CDK4/CDK6-RB1 axis ...

Thus, dronedarone appears safe for patients with a history of mild-to-moderate heart failure, but not in those with similar clinical characteristics to patients enrolled in the ANDROMEDA trial.

In this context, a study explores the potential of dronedarone, an FDA-approved drug, in inhibiting ESCC proliferation through the CDK4/CDK6-RB1 axis, both in vitro and in vivo. The research ...

Journal Article, January 26, 2012 Dronedarone: A Cautionary Tale From PALLAS While the anti-arrhythmic drug dronedarone proved safe and effective in patients with intermittent atrial fibrillation ...